Market Overview

Wedbush Defends Herbalife, Says Jan. 10th Meeting Could Be Positive Catalyst

Related HLF
Ackman: Allergan Is A Good Merger Arbitrage Play, Potential 28% Upside
Bill Ackman Says Herbalife's Business Is Declining
Global Jitters Send Wall Street Tumbling (Fox Business)

Wedbush analyst Rommel Dionisio Friday said he believes Herbalife (NYSE: HLF) will ease investor concerns during its call on January 10th by disclosing more information on internal consumption rates, SG&A expenses, and past FTC rulings.

The controversy surrounding Herbalife points to its business model resembling that of a pyramid scheme, namely that more of its revenue comes from recruiting new distributors than from actual sales. Wedbush's analysis proposes this notion is incorrect and that retail profits are actually greater than the recruiting commissions.

Wedbush said negative publicity won't have a “noticeable” impact on Herbalife's future performance and recruitment and sales should remain strong.

Wedbush maintains an Outperform rating on Herbalife shares but slashed the price target from $82 to $54.

Herbalife's Analyst and Investor Meeting is scheduled for January 10th, 2013 at 9:00am EST.

Latest Ratings for HLF

DateFirmActionFromTo
Nov 2014BarclaysMaintainsOverweight
Nov 2014BTIG ResearchInitiates Coverage onBuy
Nov 2014SunTrust Robinson HumphreyDowngradesBuyNeutral

View More Analyst Ratings for HLF
View the Latest Analyst Ratings

Posted-In: Analyst Color Price Target Analyst Ratings

 

Related Articles (HLF)

Around the Web, We're Loving...

Get Benzinga's Newsletters